Epitalon: The Telomere Peptide

Epitalon (also spelled Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on Epithalamin, a peptide extract from the pineal gland first studied by Professor Vladimir Khavinson in Russia over several decades. Epitalon's primary mechanism of action is the activation of telomerase, the enzyme responsible for maintaining telomere length. Telomeres are the protective caps on the ends of chromosomes that shorten with each cell division. When telomeres become critically short, the cell enters senescence or apoptosis. By activating telomerase, Epitalon helps maintain telomere length and extends the replicative lifespan of cells.

Beyond telomerase activation, Epitalon has been shown to normalize circadian rhythm by stimulating melatonin production from the pineal gland, regulate gene expression patterns to a more youthful profile, enhance antioxidant enzyme activity, and improve immune function. In animal studies, Epitalon treatment increased maximum lifespan by 13-31% depending on the species and study design. While human clinical trials are limited, observational data from long-term users shows improvements in sleep quality, immune function, and subjective markers of vitality.

Epitalon is typically administered in cycles: 10mg per day (split into two 5mg subcutaneous injections) for 10-20 days, repeated every 4-6 months. Some practitioners use a lower-dose continuous protocol of 1-3mg daily. The cyclic approach mirrors the dosing used in the original Russian research and is based on the principle that telomerase activation does not need to be continuous. The effects of each cycle persist for months as newly maintained telomeres continue to protect chromosomes through subsequent cell divisions.